THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS

LAUHIO A, KONTTINEN YT, SALO T, Tschesche H, NORDSTROM D, LAHDEVIRTA J, GOLUB LM, SORSA T (1994)
In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL., 732(1 Inhibition of). NEW YORK ACAD SCIENCES: 431-432.

Konferenzbeitrag | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
LAUHIO, A; KONTTINEN, YT; SALO, T; Tschesche, HaraldUniBi; NORDSTROM, D; LAHDEVIRTA, J; GOLUB, LM; SORSA, T
Einrichtung
Fakultät für Chemie > Biochemie I
Erscheinungsjahr
1994
Titel des Konferenzbandes
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL
Band
732
Ausgabe
1 Inhibition of
Seite(n)
431-432
ISSN
0077-8923
Page URI
https://pub.uni-bielefeld.de/record/1640754

Zitieren

LAUHIO A, KONTTINEN YT, SALO T, et al. THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. Vol 732. NEW YORK ACAD SCIENCES; 1994: 431-432.
LAUHIO, A., KONTTINEN, Y. T., SALO, T., Tschesche, H., NORDSTROM, D., LAHDEVIRTA, J., GOLUB, L. M., et al. (1994). THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 732, 431-432. NEW YORK ACAD SCIENCES. https://doi.org/10.1111/j.1749-6632.1994.tb24776.x
LAUHIO, A, KONTTINEN, YT, SALO, T, Tschesche, Harald, NORDSTROM, D, LAHDEVIRTA, J, GOLUB, LM, and SORSA, T. 1994. “THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 732:431-432. NEW YORK ACAD SCIENCES.
LAUHIO, A., KONTTINEN, Y. T., SALO, T., Tschesche, H., NORDSTROM, D., LAHDEVIRTA, J., GOLUB, L. M., and SORSA, T. (1994). “THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS” in INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, vol. 732, (NEW YORK ACAD SCIENCES), 431-432.
LAUHIO, A., et al., 1994. THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. no.732 NEW YORK ACAD SCIENCES, pp. 431-432.
A. LAUHIO, et al., “THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”, INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, vol. 732, NEW YORK ACAD SCIENCES, 1994, pp.431-432.
LAUHIO, A., KONTTINEN, Y.T., SALO, T., Tschesche, H., NORDSTROM, D., LAHDEVIRTA, J., GOLUB, L.M., SORSA, T.: THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. 732, p. 431-432. NEW YORK ACAD SCIENCES (1994).
LAUHIO, A, KONTTINEN, YT, SALO, T, Tschesche, Harald, NORDSTROM, D, LAHDEVIRTA, J, GOLUB, LM, and SORSA, T. “THE IN-VIVO EFFECT OF DOXYCYCLINE TREATMENT ON MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. NEW YORK ACAD SCIENCES, 1994.Vol. 732. 431-432.

6 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
Wang X, Chow FL, Oka T, Hao L, Lopez-Campistrous A, Kelly S, Cooper S, Odenbach J, Finegan BA, Schulz R, Kassiri Z, Lopaschuk GD, Fernandez-Patron C., Circulation 119(18), 2009
PMID: 19398663
Chemically modified tetracyclines as inhibitors of matrix metalloproteinases.
Acharya MR, Venitz J, Figg WD, Sparreboom A., Drug Resist Updat 7(3), 2004
PMID: 15296861
Doxycycline improves wound strength after intestinal anastomosis in the rat.
Siemonsma MA, de Hingh IH, de Man BM, Lomme RM, Verhofstad AA, Hendriks T., Surgery 133(3), 2003
PMID: 12660638
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, Sicard GA, Thompson RW., J Vasc Surg 31(2), 2000
PMID: 10664501
Tetracyclines and the treatment of corneal stromal ulceration: a review.
Ralph RA., Cornea 19(3), 2000
PMID: 10832682
Characterization of interstitial collagenases in jaw cyst wall.
Teronen O, Salo T, Laitinen J, Törnwall J, Ylipaavalniemi P, Konttinen YT, Hietanen J, Sorsa T., Eur J Oral Sci 103(3), 1995
PMID: 7634129

5 References

Daten bereitgestellt von Europe PubMed Central.

Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS., J. Periodont. Res. 18(5), 1983
PMID: 6315909

Lauhio, Arthritis Rheum 24(), 1991
The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis.
Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT., Arthritis Rheum. 35(2), 1992
PMID: 1310409

Lauhio, Antimi-crob. Agents Chemother 38(), 1994
The regulatory role of doxycycline/tetracycline in collagenolytic activity and tissue destruction in joint diseases: comment on the article by Yu et al.
Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT., Arthritis Rheum. 36(9), 1993
PMID: 8216431
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 7978830
PubMed | Europe PMC

Suchen in

Google Scholar